Moreover, when considering druggable gene alterations at pathway level, we found that genes involved in cell cycle regulation, such as TP53, CCND1, CDK6, RB1, and CDKN2A, were altered in early stage whereas genes involved in RTK/RAS/PI3K tend to be altered throughout the process of tumor evolution. Here, CDKN2A is linked to neoplasm.